| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adaptive immune response to a wild boar-derived recombinant hepatitis e virus capsid protein challenge in pigs
|
Grigas, Juozas
|
|
|
44 |
C |
p.
|
artikel
|
| 2 |
Addressing vaccine misinformation: The critical need for complete product information disclosure
|
Pitts, Peter J.
|
|
|
44 |
C |
p.
|
artikel
|
| 3 |
Assessing human B cell responses to influenza virus vaccines and adjuvants in a PBMC-derived in vitro culture system
|
Gong, Shuran
|
|
|
44 |
C |
p.
|
artikel
|
| 4 |
Association of baseline cytokines with antibody concentrations after diphtheria-tetanus-acellular pertussis booster vaccination in Finnish children
|
Anabe, Denise
|
|
|
44 |
C |
p.
|
artikel
|
| 5 |
Associations between family planning, healthcare access, and female education and vaccination among under-immunized children
|
Castillo-Zunino, Francisco
|
|
|
44 |
C |
p.
|
artikel
|
| 6 |
Challenges of using the test-negative design to measure vaccine effectiveness of multi-pathogen combination vaccines targeting one syndrome
|
Kim, Sara S.
|
|
|
44 |
C |
p.
|
artikel
|
| 7 |
Conceptual debates in the study of canine & feline vaccine hesitancy: A response to Haeder 2023
|
Motta, Matt
|
|
|
44 |
C |
p.
|
artikel
|
| 8 |
Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039–3048]
|
Schultze, Anna
|
|
|
44 |
C |
p.
|
artikel
|
| 9 |
Corrigendum to “Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina” [Vaccine. Volume 42, Issue 23, 3 October 2024, 126234]
|
Guiñazú, Gonzalo
|
|
|
44 |
C |
p.
|
artikel
|
| 10 |
Corrigendum to “Immunogenicity during 6 months after SARS-CoV-2 infection is significantly different depending on previous COVID-19 vaccine regimens and a booster dose received” [Vaccine 42 (22) (2024) 126025]
|
Sritipsukho, Paskorn
|
|
|
44 |
C |
p.
|
artikel
|
| 11 |
Corrigendum to “Influenza B/Yamagata - extinct, eradicated or hiding? [Vaccine 42/26 (2024) 126450]”
|
MacIntyre, Chandini R.
|
|
|
44 |
C |
p.
|
artikel
|
| 12 |
Cost-effectiveness of 15-valent or 20-valent pneumococcal conjugate vaccine for U.S. adults aged 65 years and older and adults 19 years and older with underlying conditions
|
Rosenthal, Melissa
|
|
|
44 |
C |
p.
|
artikel
|
| 13 |
COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study
|
Piché-Renaud, Pierre-Philippe
|
|
|
44 |
C |
p.
|
artikel
|
| 14 |
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients
|
Gemander, Nicolas
|
|
|
44 |
C |
p.
|
artikel
|
| 15 |
Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis
|
Blukacz, Alice
|
|
|
44 |
C |
p.
|
artikel
|
| 16 |
Differences in knowledge, attitudes and intentions towards HPV vaccination among young adults from diverse socio-cultural groups in Israel: A cross-sectional study
|
Edelstein, Michael
|
|
|
44 |
C |
p.
|
artikel
|
| 17 |
Editorial Board
|
|
|
|
44 |
C |
p.
|
artikel
|
| 18 |
Effectiveness of BNT162b2 and CoronaVac against COVID-19-related severe outcomes among children and adolescents: A Brazilian nationwide cohort study
|
de Lima, Eliandra da Silveira
|
|
|
44 |
C |
p.
|
artikel
|
| 19 |
Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in older adults
|
Hsiao, Amber
|
|
|
44 |
C |
p.
|
artikel
|
| 20 |
Exploring Chatbot contributions to enhancing vaccine literacy and uptake: A scoping review of the literature
|
Cosma, Claudia
|
|
|
44 |
C |
p.
|
artikel
|
| 21 |
Guillain-Barré syndrome temporally associated with COVID-19 vaccines – Progress over time
|
Laemmle-Ruff, Ingrid
|
|
|
44 |
C |
p.
|
artikel
|
| 22 |
Human papillomavirus vaccination coverage among adolescent boys and girls in the United States: A birth year cohort analysis of the National Immunization Survey-Teen, 2016–2022.
|
Nyika, Ponesai
|
|
|
44 |
C |
p.
|
artikel
|
| 23 |
Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice
|
Matthews, Rebecca L.
|
|
|
44 |
C |
p.
|
artikel
|
| 24 |
Immunoprotective efficacy of Escherichia coli-derived outer membrane vesicles displaying PlpE protein of Pasteurella multocida
|
Li, Yajuan
|
|
|
44 |
C |
p.
|
artikel
|
| 25 |
Influenza B/Yamagata cannot currently be declared extinct
|
MacIntyre, Chandini R.
|
|
|
44 |
C |
p.
|
artikel
|
| 26 |
Investigating parental perceptions of respiratory syncytial virus (RSV) and attitudes to RSV vaccine in Jiangsu, China: Insights from a cross-section study
|
Wang, Qiang
|
|
|
44 |
C |
p.
|
artikel
|
| 27 |
Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST)
|
Marchese, Anthony M.
|
|
|
44 |
C |
p.
|
artikel
|
| 28 |
No person left behind: Understanding vaccine hesitancy in low- and middle-income countries
|
Tyagi, Alvira
|
|
|
44 |
C |
p.
|
artikel
|
| 29 |
One-year follow-up evaluation of approved Subolesin anti-tick vaccine in Uganda
|
Kasaija, Paul D.
|
|
|
44 |
C |
p.
|
artikel
|
| 30 |
Protection induced by Streptococcus pneumoniae extracellular vesicles against nasal colonization and invasive infection in mice and the role of PspA
|
Carneiro, Giovanna B.
|
|
|
44 |
C |
p.
|
artikel
|
| 31 |
Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity
|
Hodgson, David
|
|
|
44 |
C |
p.
|
artikel
|
| 32 |
Reflections on two decades at the helm and the evolving landscape of scientific publishing
|
Poland, Gregory A.
|
|
|
44 |
C |
p.
|
artikel
|
| 33 |
Respiratory syncytial virus (RSV) prevention: Perception and willingness of expectant parents in the Netherlands
|
Harteveld, Lisette M.
|
|
|
44 |
C |
p.
|
artikel
|
| 34 |
Return of poliomyelitis: A real risk in a country afflicted by scientific denialism
|
Silva, Heslley Machado
|
|
|
44 |
C |
p.
|
artikel
|
| 35 |
Re: Using observational data to explore the hypothesis that a single dose of current HPV vaccines can provide durable protection
|
Muwonge, Richard
|
|
|
44 |
C |
p.
|
artikel
|
| 36 |
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial
|
Thiem, Vu Dinh
|
|
|
44 |
C |
p.
|
artikel
|
| 37 |
Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naïve Japanese adults: A phase 1 randomized dose-escalation trial
|
Borys, Dorota
|
|
|
44 |
C |
p.
|
artikel
|
| 38 |
Sex differences in parental reasons for lack of intent to initiate HPV vaccination among adolescents ages 13-17 years: National Immunization Survey – Teen 2019-2021
|
Escabí-Wojna, Erika
|
|
|
44 |
C |
p.
|
artikel
|
| 39 |
Social complexity of a fentanyl vaccine to prevent opioid overdose conference proceedings: Radcliffe Institute for Advanced Study conference proceedings
|
Weitzman, Elissa R.
|
|
|
44 |
C |
p.
|
artikel
|
| 40 |
The effectiveness of vaccines against COVID-19 in Mexico: A time series approach
|
Flores, D.
|
|
|
44 |
C |
p.
|
artikel
|
| 41 |
The evidence base for rotavirus vaccination in India: Current status, future needs
|
Bhat, Niranjan
|
|
|
44 |
C |
p.
|
artikel
|
| 42 |
The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: Propensity score-matched analysis with influenza vaccination
|
Choi, Yu Jung
|
|
|
44 |
C |
p.
|
artikel
|
| 43 |
The stability of PCV2 virus-like particles from mammalian cells and challenges for biotechnological applications
|
Olivero-Deibe, Natalia
|
|
|
44 |
C |
p.
|
artikel
|
| 44 |
The trend in national childhood immunization program coverage throughout Serbian communities in Kosovo and Metohija from 2003 to 2022: pre-COVID-19 period vs. COVID-19 pandemic
|
Filimonovic, Jelena
|
|
|
44 |
C |
p.
|
artikel
|
| 45 |
Use of experimental vaccines is ethically permissible during public health emergencies
|
Mastroleo, Ignacio
|
|
|
44 |
C |
p.
|
artikel
|
| 46 |
Use of social media and its influence on HPV vaccine hesitancy: US National Online Survey of mothers of adolescents, 2023
|
Liebermann, Erica
|
|
|
44 |
C |
p.
|
artikel
|
| 47 |
Using human papillomavirus (HPV) vaccine in controlled temperature chain (CTC): A solution looking for a problem? Or a solution to problems that are not systematically documented?
|
Spasenoska, Dijana
|
|
|
44 |
C |
p.
|
artikel
|
| 48 |
Vaccine for hand, foot, and mouth disease (HFMD): A call to action
|
Gam, Pham Hong
|
|
|
44 |
C |
p.
|
artikel
|
Tijdschrift beschrijving